Ignite Creation Date:
2025-12-24 @ 12:18 PM
Ignite Modification Date:
2026-04-13 @ 9:34 PM
Study NCT ID:
NCT06384261
Status:
RECRUITING
Last Update Posted:
2025-09-10
First Post:
2024-04-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed AML Ineligible for Intensive Therapy
Sponsor:
OncoVerity, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
OV-AML-1231
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None